CC
AEON icon

Centiva Capital’s AEON Biopharma AEON Stock Holding History

Centiva Capital’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,159
Closed -$839K – 1484
2022
Q4 		$839K Hold
1,159
– – 0.02% 623
2022
Q3 		$822K Hold
1,159
– – 0.02% 701
2022
Q2 		$817K Buy
1,159
+20
+2% +$14.1K 0.02% 710
2022
Q1 		$802K Buy
1,139
+720
+172% +$505K 0.02% 793
2021
Q4 		$294K Hold
419
– – 0.01% 922
2021
Q3 		$294K Hold
419
– – 0.02% 789
2021
Q2 		$291K Buy
+419
New +$293K 0.01% 1058

Other funds holding AEON

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Centiva Capital's AEON Position: Q1 2023 in Review

Centiva Capital sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 1,159 shares — an estimated $839K sold.

Centiva Capital first reported a position in AEON in Q2 2021 and held it in 7 quarters. The position peaked at $839K in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Centiva Capital reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Centiva Capital sold 1,159 AEON Biopharma shares in Q1 2023, an estimated $839K.
  • Centiva Capital first reported a position in AEON Biopharma in Q2 2021 and held it in 7 quarters.
  • Centiva Capital's AEON Biopharma position peaked at $839K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Centiva Capital's 13F filing for Q1 2023, filed 15 May 2023.